Skip to main content

Sandra Mancilla Zamora

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sandra Mancilla Zamora

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Degrees:
Stable animal experimentation course. ABC function in 2020
Senior Clinical Analysis Technician in 2005
Higher Techniques in Pathological Anatomy and Cytology in 2001.

Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017
Technician in charge of the histology section of FVPR and the DDT group of the VHIR.
With knowledge in environment and quality management at ISO 9001. Application management, internal positions…
They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune.
I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing.
Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.

Projects

CancerScan: Smart pathology slide scanner for diagnosis and patient-specific treatment recommendation in oncology

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Joaquin Seras Franzoso, CancerScan: Smart pathology slide scanner for diagnosis and patient-specific treatment recommendation in oncology, CancerScan: Smart pathology slide scanner for diagnosis and patient-specific treatment recommendation in oncology, Sandra Mancilla Zamora, Marc Miquel Moltó Abad, Gisela Espriu Aguado, Sonia Borao Arriazu
Funding agency: EUROPEAN COMMISSION
Funding: 609600
Reference: CANCERSCAN_RAMON Y CAJAL_EC/PATHFINDER_OPEN2024
Duration: 01/08/2025 - 31/07/2028

Hidrogeles Inteligentes y Biodegradables como Sistemas de Depósito para la Liberación Intraperitoneal Sostenida de Quimioterapéuticos para el Tratamiento Local del Cáncer de Ovario Avanzado (Smart-InOva)

IP: Diana Fernandes de Rafael
Collaborators: Julia German Cortes, Fco Javier De la Torre Fdez de Vega, Simon Schwartz Navarro, Sandra Mancilla Zamora, Belen Garcia Prats
Funding agency: Instituto de Salud Carlos III
Funding: 177500
Reference: PI24/00745
Duration: 01/01/2025 - 31/12/2027

ERDERA: European Rare Disease Research Alliance

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Sara Isabel Reidel , Miguel Chillon Rodriguez, Esther García Pagès, Raquel Mosull del Campo, Raquel Mosull del Campo, Simon Schwartz Navarro, Agustín Arasanz Duque, Sandra Mancilla Zamora, Anna Collado Gimbert, Marc Miquel Moltó Abad, Ángela Menárguez López, Ángela Menárguez López, Ángela Menárguez López, Claire Diot
Funding agency: EUROPEAN COMMISSION
Funding: 771525
Reference: ERDERA_MAÑU_EC_HLTH2023-DISEASE-07-01/2023
Duration: 01/09/2024 - 31/08/2031

TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas

IP: Begoña Benito Villabriga
Collaborators: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, Belen Perez Dueñas, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Maria Jose Pérez García, Miguel Segura Ginard, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Cristina Auger Acosta, Neus Bellera Gotarda, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno Garcia del Blanco, Ana Vivancos Prellezo, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Sandra Mancilla Zamora, Ana Zabalza de Torres, Marc Miquel Moltó Abad, Javier Inserte Igual, Luciana Midaglia Fernandez, Gabriela Guillén Burrieza, David Gómez Andrés, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Jaume Capdevila Castillon, Nicolás Miguel Fissolo , Maria Nazarena Pizzi, Paolo Giovanni Nuciforo, Tian Tian, Andrea Guala , Juan Pablo Betancur Rengifo
Funding agency: Instituto de Salud Carlos III
Funding: 2494527.53
Reference: FORT23/00034
Duration: 01/01/2024 - 31/12/2027

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

Related professionals

David Silva Soto

David Silva Soto

Research technician
Childhood Cancer and Blood Disorders
Read more
Jose Maria Suriñach Caralt

Jose Maria Suriñach Caralt

Senior researcher
Systemic Diseases
Read more
Eva Roldán Alarcón

Eva Roldán Alarcón

Junior researcher
Maternal and Fetal Medicine
Read more
Marc Bernaus Esqué

Marc Bernaus Esqué

Postdoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.